Fan Yang

Prof. Fan Yang

Department of Neurology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
ZYZhenzhen Yan
Zhenzhen Yan
FYFan Yang
Fan Yang
JCJingwei Cao
Jingwei Cao
WDWencai Ding
Wencai Ding
SYShi Yan
Shi Yan
LYLifen Yao
Lifen Yao

17 September 2022 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
ZYZhenzhen Yan
Zhenzhen Yan
FYFan Yang
Fan Yang
LSLinlin Sun
Linlin Sun
JYJing Yu
Jing Yu
LSLina Sun
Lina Sun
LYLifen Yao
Lifen Yao

2 April 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
PQPusheng Quan
Pusheng Quan
XLXueying Li
Xueying Li
YSYao Si
Yao Si
LSLinlin Sun
Linlin Sun
FDFei Fan Ding
Fei Fan Ding
LYLifen Yao
Lifen Yao
The pathogenesis of Parkinson’s disease (PD) is strongly associated with neuroinflammation, and type I interferons (IFN-I) play a crucial role in regulating immune and inflammatory responses. However, the specific features of IFN in different cell types and the underlying mechanisms of PD have yet to be fully described. In this study, we analyzed the GSE157783 dataset, which includes 39,024 single-cell RNA sequencing results for five PD patients and six healthy controls from the Gene Expression Omnibus database. After cell type annotation, we intersected differentially expressed genes in each cell subcluster with genes collected in The Interferome database to generate an IFN-I-stimulated gene set (ISGs). Based on this gene set, we used the R package AUCell to score each cell, representing the IFN-I activity. Additionally, we performed monocle trajectory analysis, and single-cell regulatory network inference and clustering (SCENIC) to uncover the underlying mechanisms. In silico gene perturbation and subsequent experiments confirm NFATc2 regulation of type I interferon response and neuroinflammation. Our analysis revealed that microglia, endothelial cells, and pericytes exhibited the highest activity of IFN-I. Furthermore, single-cell trajectory detection demonstrated that microglia in the midbrain of PD patients were in a pro-inflammatory activation state, which was validated in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model as well. We identified transcription factors NFATc2, which was significantly up-regulated and involved in the expression of ISGs and activation of microglia in PD. In the 1-Methyl-4-phenylpyridinium (MPP+)-induced BV2 cell model, the suppression of NFATc2 resulted in a reduction in IFN-β levels, impeding the phosphorylation of STAT1, and attenuating the activation of the NF-κB pathway. Furthermore, the downregulation of NFATc2 mitigated the detrimental effects on SH-SY5Y cells co-cultured in conditioned medium. Our study highlights the critical role of microglia in type I interferon responses in PD. Additionally, we identified transcription factors NFATc2 as key regulators of aberrant type I interferon responses and microglial pro-inflammatory activation in PD. These findings provide new insights into the pathogenesis of PD and may have implications for the development of novel therapeutic strategies.

21 March 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SYShi Yan
Shi Yan
YSYao Si
Yao Si
WZWenyang Zhou
Wenyang Zhou
RCRui Cheng
Rui Cheng
PWPingping Wang
Pingping Wang
LYLifen Yao
Lifen Yao

1 January 2023 in Open Medicine
Verified
Journal Article
Open access
PDF file
NMNa Mi
Na Mi
LMLili Ma
Lili Ma
XLXueying Li
Xueying Li
JFJia Fu
Jia Fu
XBXinxin Bu
Xinxin Bu
LYLifen Yao
Lifen Yao
The gut microbiota and microbial metabolites influence the enteric nervous system and the central nervous system via the microbial–gut–brain axis. Increasing body of evidence suggests that disturbances in the metabolism of peripheral branched-chain amino acids (BCAAs) can contribute to the development of neurodegenerative diseases through neuroinflammatory signaling. Preliminary research has shown that longitudinal changes in serum amino acid levels in mouse models of Parkinson’s disease (PD) are negatively correlated with disease progression. Therefore, the aim of the present study was to determine the changes in serum levels of short-chain fatty acids (SCFAs) in a mouse model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD after dietary BCAA supplementation. In our research, gas chromatography–mass spectrometry was used to detect serum SCFA concentrations. The data were then analyzed with principal component analysis and orthogonal partial least squares discriminant analysis. Finally, the correlations of serum SCFA levels with gut and motor function in MPTP-induced PD mice were explored. Propionic acid, acetic acid, butyric acid, and isobutyric acid concentrations were elevated in MPTP + H-BCAA mice compared with MPTP mice. Propionic acid concentration was increased the most, while the isovaleric acid concentration was decreased. Propionic acid concentration was positively correlated with fecal weight and water content and negatively correlated with the pole-climbing duration. In conclusion, these results not only suggest that propionic acid may be a potential biomarker for PD, but also indicate the possibility that PD may be treated by altering circulating levels of SCFA.

8 July 2025 in Brain Research
Verified
Journal Article
Closed access
YSYao Si
Yao Si
SYShi Yan
Shi Yan
XLXueying Li
Xueying Li
WDWencai Ding
Wencai Ding
XZXinyu Zhang
Xinyu Zhang
WSWanying Shi
Wanying Shi